Christian Kessler
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Christian Kessler has a total of 5 co-authors. Here are the top co-authors by number of shared publications:
- Andreas Karau
Evonik Nutrition & Care GmbH, Business Line Health Care, Kirschenallee, 64293 Darmstadt, Germany
1 shared publication - Andrés Sánchez-Kopper
Centro de Investigación y de Servicios Químicos y Microbiológicos, Escuela de Química, Instituto Tecnológico de Costa Rica, Cartago P.O. Box 159-7050, Costa Rica
1 shared publication - Jennifer Pfizenmaier
Institute of Biochemical Engineering, University of Stuttgart, Allmandring 31, 70569, Stuttgart, Germany
1 shared publication - Max Becker
Institute of Biochemical Engineering, University of Stuttgart, Allmandring 31, 70569, Stuttgart, Germany
1 shared publication - Ralf Takors
Institute of Biochemical Engineering, University of Stuttgart, Stuttgart, Germany
1 shared publication
Latest Publications
- Open Access
- 22 July 2016
- Published by Springer Nature in AMB Express
- Vol. 6 (1) , 1-12
Tracking dipeptides at work-uptake and intracellular fate in CHO culture
Market demands for monoclonal antibodies (mAbs) are steadily increasing worldwide. As a result, production processes using Chinese hamster ovary cells (CHO) are in the focus of ongoing intensification studies for maximizing cell-specific and volumetric productivities. This includes the optimization of animal-derived component free (ADCF) cultivation media as part of good cell culture practice. Dipeptides are known to improve CHO culture performance. However, little or even conflicting assumptions exist about their putative import and functionality inside the cells. A set of well-known performance boosters and new dipeptide prospects was evaluated. The present study revealed that dipeptides are indeed imported in the cells, where they are decomposed to the amino acids building blocks. Subsequently, they are metabolized or, unexpectedly, secreted to the medium. Monoclonal antibody production boosting additives like l-alanine-l-glutamine (AQ) or glycyl-l-glutamine (GQ) can be assigned to fast or slow dipeptide uptake, respectively, thus pinpointing to the need to study dipeptide kinetics and to adjust their feeding individually for optimizing mAb production.
- 22 July 2016
- Published by Springer Nature in AMB Express
- Vol. 6 (1) , 1-12
Open AccessTracking dipeptides at work-uptake and intracellular fate in CHO culture
Market demands for monoclonal antibodies (mAbs) are steadily increasing worldwide. As a result, production processes using Chinese hamster ovary cells (CHO) are in the focus of ongoing intensification studies for maximizing cell-specific and volumetric productivities. This includes the optimization of animal-derived component free (ADCF) cultivation media as part of good cell culture practice. Dipeptides are known to improve CHO culture performance. However, little or even conflicting assumptions exist about their putative import and functionality inside the cells. A set of well-known performance boosters and new dipeptide prospects was evaluated. The present study revealed that dipeptides are indeed imported in the cells, where they are decomposed to the amino acids building blocks. Subsequently, they are metabolized or, unexpectedly, secreted to the medium. Monoclonal antibody production boosting additives like l-alanine-l-glutamine (AQ) or glycyl-l-glutamine (GQ) can be assigned to fast or slow dipeptide uptake, respectively, thus pinpointing to the need to study dipeptide kinetics and to adjust their feeding individually for optimizing mAb production.